Imperial College London

ProfessorSimonTaylor-Robinson

Central FacultyOffice of the President

President's Envoy for International Affairs
 
 
 
//

Contact

 

s.taylor-robinson

 
 
//

Location

 

1008aQueen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Collaborators

Professor Saeed Hamid, Agha Khan University, Karachi, Pakistan, Liver Cancer - joint Wellcome application, 2013

Professor David Jones, University of Newcastle, Primary Biliary Cirrhosis: MRC STRATIFIED MEDICINE GRANT ON PRIMARY BILIARY CIRRHOSIS: (joint with Newcastle, Birmingham and Cambridge £5,500,000 (£500,000 to Imperial) July 2013-July 2017 (with Professor David Jones, Newcastle as PI)., 2013 - 2017

Dr Gideon Hirschfield, University of Birmingham, Primary Biliary Cirrhosis: MRC STRATIFIED MEDICINE GRANT ON PRIMARY BILIARY CIRRHOSIS: (joint with Newcastle, Birmingham and Cambridge £5,500,000 (£500,000 to Imperial) July 2013-July 2017 (with Professor David Jones, Newcastle as PI)., 2013 - 2017

Dr George Mells, Cambridge University, Primary Biliary Cirrhosis: MRC STRATIFIED MEDICINE GRANT ON PRIMARY BILIARY CIRRHOSIS: (joint with Newcastle, Birmingham and Cambridge £5,500,000 (£500,000 to Imperial) July 2013-July 2017 (with Professor David Jones, Newcastle as PI)., 2013 - 2017

Professor Hidekatsu Kuroda, Iwate Medical School, Morioka, Japan, Hepatic Encephalopathy. Professor Kuroda is coming to Imperial on a two year sabbatical to work in our research team, 2012

Professor Abdusamad Dustov, Institute of Gastroenterology, Dushanbe, Tajikistan, ASSOCIATION OF PHYSICIANS OF GREAT BRITAIN AND IRELAND: £15,000 - Overseas Development Grant: for study on metabonomics of hepatocellular carcinoma in aTajik population with chronic hepatitis B., 2012

Professor Lewis RobertsProfessor Gregory Gores, Mayo Clinic, Rochester, Minnesota, USA, Cholangiocarcinoma. Abigail Zabron in our Research Group won the Sheila Sherlock Award from the Royal College of Physicians in 2011 to unertake collaborative work., 2011

Professor Jasmohan Bajaj, Virginia Commonwealth University, Hepatic Encephalopathy: CoI on a NIH grant, 2011

Professor Mourtalla Ka, Thies Medical School, Thies, Senegal, PROLIFICA EU-Framework 7 grant: Prevention of Liver Fibrosis and Liver Cancer in Africa, 2011

Professor Tumani Corrah, Dr Umberto D'Alessandro, MRC Gambia, PROLIFICA EU-Framework 7 Grant on liver fibrosis and liver cancer in Africa, 2011

Benedikt Kessler, University of Oxford, Hepatocellular carcinoma biomarkers, 2011

Professor Souleymanne Mboup, Le Dantec Hospital, Dakar, Senegal, PROLIFICA EU Frameork 7 Grant: Prevention of Liver Fibrosis and Liver Cancer in Africa., 2011

Dr Debbie ShawcrossProfessor Julia Wendon, King's College London, Acute Liver Failure and Hepatic EncephalopathyWELLCOME TRUST: £150,000: “ACUTE LIVER FAILURE AND HEPATIC ENCEPHALOPATHY” October 2010-October 2012 to fund post-doctoral fellow: Dr Mark McPhail., 2010

Professor Paiboon Sithithaworn and team, Khon Kaen University Liver Fluke and Cholangiocarcinoma Centre, Liver fluke and cholangiocarcinoma biomarkers (part of the Wellcome Global Centre at Imperial), 2010

Professor Kirsten Muri Boberg, University of Oslo, Norway/Oslo University Hospital, Cholangiocarcinoma, 2010

Professor Mamun Al Mahtab, Institute of Hepatology, Bangabandhu Sheikh Mujib MEdical University, Dhaka, Bangladesh, liver cancer, viral hepatitis, metabonomics, 2006

Dr Edith Okeke, Jos University Teaching Hospital, Jos, Plateau State, Nigeria, PROLIFICA EU-Framework 7 Grant on liver fibrosis and liver cancer in Africa, 2006

Dr Sara MontagneseProfessor Piero Amodio, University of Padova, Hepatic Encephalopathy. Collaboration through ISHEN, 2006

Professor Imam Waked, National Liver Institute, Menoufiya, Egypt, Viral hepatitis, liver cancer and cholangiocarcinoma. We have hosted several Egyptian MD students (Asmaa Ibrahim Gomaa, Mohamed Saad, Gamal Badra) - one of whom was the beneficiary of a Royal Society Fellowship, 2006

Professor Margaret Bassendine, Newcastle University, 6. MEDICAL RESEARCH COUNCIL: £868,000 March 2007 – February 2011: “Hepatitis C Virus: Host-Lipid Interactions – A novel Application for Lipid Modulating Agents” G0502028. This study on viral kinetics and lipoprotein profiles will be undertaken on a group of patients receiving fish oils and statins – which experimentally alter the host susceptibility to continued viral infection. (co-grant holders: Professor M Bassendine, Professor HC Thomas, Dr G Toms)., 2004

Professor Karin Weissenborn, University of Hannover, Hepatic Encephalopathy, 2002

Guest Lectures

fMRI in Hepatic Encephalopathy, European Association for the Study of the Liver, Amsterdam, Netherlands, 2013

Non-Surgical Treatment of Cholangiocarcinoma, European Association for the Study of the Liver, Barcelona, 2012

PROLIFICA project, European Association for the Study of the Liver:, Barcelona, Spain, 2012

Biomarkers of Liver Fibrosis, Bangladesh Liver Association, Dhaka, Bangladesh, 2010

“Imaging of Basal Ganglia”, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) meeting,, Montreal, Canada,, 2010

Imaging in Hepatic Encephalopathy, Japanese Society of Hepatic Encephalopathy, Tokyo, Japan, 2010

Hepatocellular Carcinoma: Diagnosis and Surveillance Strategies., Norwegian National Liver Disease Meeting, Oslo, Norway, 2010

Imaging of Non-Alcoholic Fatty Liver Disease (State-of-the-Art), European Association for the Study of the Liver: monothematic conference on NAFLD, Bologna, Italy, 2009

“Liver Biochemistry in vivo”, British Association for the Study of the Liver., London, UK, 2009

PET and Imaging in Hepatic Encephalopathy, Japanese Society of Hepatic Encephalopathy, Morioka, Japan, 2009

“Non-invasive Assessment of Liver Fibrosis”, British Viral Hepatitis Group, London, King's Fund, London, 2009

PET kinetics in Hepatic Encephalopathy, European Association for the Study of the Liver, (Copenhagen, Denmark)., 2009

"Non-invasive Liver Biopsy Techniques” ;, Royal College of Physicians of London, Advanced Medicine Course,, Royal College of Physicians of London, 2009

Cholangiocarcinoma Epidemiology, Royal Society of Medicine, Royal Society of Medicine, London, 2009

Hepatitis C Virus and its Cerebral Effects, International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) , ., Padova, Italy, 2008

Hepatitis C and the Brain., EISH Meeting, Prague, Czech Republic, 2007

Update on hepatic encephalopathy., European Association for the Study of the Liver, Barcelona, Spain, 2007

Imaging in Liver Disease, University of California at San Diego, San Diego, USA, University of California at San Diego, San Diego, USA, 2006

“Hepatitis C and the Brain – What to measure?”, International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) ,, Dusseldorf, 2005

Royal College of Physicians Regional Lecture (New Imaging Techniques in the Liver), Royal College of Physicians, 2004

“Extrahepatic manifestations of Hepatitis C”, NIH Single Topic Conference, Washington DC October 2003, NIH, Bethesda, Maryland, USA, 2003

"Cholangiocarcinoma: An Increasing Problem?" Keynote Address, British Society of Gastroenterology, Glasgow, 2001

Linacre Lecture, Royal College of Physicians, 2000

Research Staff

Crossey,MM

Research Student Supervision

Bak-Bol,A, Meta-analysis of Hepatic Encephalopathy Treatments

Cook,N, Psychometric Testing in Hepatic Encephalopathy

Jakubova,R, Proteomics in Cholangiocarcinoma

Leahy,M, Audit of Hepatocellular Carcinoma Practice

Patel,D, Ultrasound Microbubbles in Liver Disease

Patel,M, Lactulose withdrawal in Hepatic Encephalopathy

Posner,H, Projects on viral hepatitis in Gambia (PROLIFICA)

Ratneswaran,M, Urinary Metabonomics of Hepatic Encephalopathy

Senvar,N, Meta-analysis of Hepatic Encephalopathy Treatment Interventions with Psychometric Testing

Torlot,F, Meta-analysis of Critical Flicker Frequency